Updated TAR Criteria for Breast and Ovarian Cancer Gene Analysis

Effective for dates of service on or after April 1, 2016, Treatment Authorization Request (TAR) criteria have been updated for CPT codes 81211 (BRCA1, BRCA2 gene analysis; full sequence analysis and common duplication/deletion variants in BCRA1) and 81213 (uncommon duplication/deletion variants). Providers may refer to the appropriate section of the Part 2 provider manual to review the updated TAR criteria.